CVS Health Co. (NYSE:CVS) Shares Sold by Dynamic Advisor Solutions LLC

Dynamic Advisor Solutions LLC cut its holdings in CVS Health Co. (NYSE:CVSFree Report) by 55.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 19,206 shares of the pharmacy operator’s stock after selling 23,646 shares during the period. Dynamic Advisor Solutions LLC’s holdings in CVS Health were worth $862,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health during the 3rd quarter worth $25,000. Ridgewood Investments LLC boosted its stake in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares during the period. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health during the third quarter valued at about $31,000. Legacy Investment Solutions LLC acquired a new position in shares of CVS Health in the 3rd quarter worth approximately $31,000. Finally, Reston Wealth Management LLC purchased a new position in shares of CVS Health during the 3rd quarter worth approximately $32,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Trading Up 1.6 %

NYSE:CVS opened at $54.71 on Monday. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $80.75. The stock has a market cap of $68.84 billion, a P/E ratio of 13.88, a P/E/G ratio of 0.80 and a beta of 0.59. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock has a 50-day simple moving average of $51.24 and a 200-day simple moving average of $56.21.

CVS Health (NYSE:CVSGet Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm’s revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the firm posted $2.21 earnings per share. As a group, analysts anticipate that CVS Health Co. will post 5.22 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be paid a $0.665 dividend. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.86%. CVS Health’s dividend payout ratio is presently 67.51%.

Wall Street Analyst Weigh In

A number of research analysts have commented on CVS shares. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. Royal Bank of Canada decreased their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research note on Friday, November 15th. Barclays dropped their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. StockNews.com lowered shares of CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Finally, Truist Financial cut their target price on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and an average price target of $68.71.

Get Our Latest Report on CVS

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Stories

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.